LRMR insider trading
Larimar Therapeutics, Inc.
In the past 68 days, 8 insiders bought $392K of Larimar Therapeutics, Inc. stock in 8 open-market purchases. The largest purchase was $187K by Thomas Edward Hamilton (Director) on Nov 12, 2026.
Cluster buying: 8 different insiders bought $392K between Nov 11, 2026 and Nov 16, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
Jeffrey W Sherman Director |
$10K 3,289 sh @ $3.06 |
+65.8% | Medium
|
Nov 16, 2026 Filed Nov 16, 2026 |
Thomas Edward Hamilton Director |
$187K 70,000 sh @ $2.67 |
New position | High
|
Nov 12, 2026 Filed Nov 12, 2026 |
Michael Celano Chief Financial Officer |
$50K 18,460 sh @ $2.71 |
+8.6% | Medium
|
Nov 11, 2026 Filed Nov 12, 2026 |
Carole Ben-Maimon President and CEO |
$50K 18,050 sh @ $2.77 |
+4.9% | Medium
|
Nov 11, 2026 Filed Nov 12, 2026 |
John B. Harlow Jr. President and COO |
$50K 17,800 sh @ $2.80 |
+35.6% | Medium
|
Nov 11, 2026 Filed Nov 12, 2026 |
Frank E Thomas Director |
$22K 8,000 sh @ $2.73 |
+114.3% | Medium
|
Nov 11, 2026 Filed Nov 12, 2026 |
Gopi Shankar Chief Development Officer |
$14K 5,000 sh @ $2.71 |
+6.5% | Low
|
Nov 11, 2026 Filed Nov 12, 2026 |
Joseph Truitt Director |
$10K 3,500 sh @ $2.80 |
+127.3% | Medium
|
Nov 11, 2026 Filed Nov 12, 2026 |
Insider sales
No open-market sales by insiders in this period.
The week's top insider buys, every Monday
Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.
Unsubscribe any time. No spam, no stock picks.